Literature DB >> 26804616

Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake.

S Schöttler1, Katja Klein2, K Landfester2, V Mailänder1.   

Abstract

Protein adsorption on nanoparticles has been a focus of the field of nanocarrier research in the past few years and more and more papers are dealing with increasingly detailed lists of proteins adsorbed to a plethora of nanocarriers. While there is an urgent need to understand the influence of this protein corona on nanocarriers' interactions with cells the strong impact of the protein source on corona formation and the consequence for interaction with different cell types are factors that are regularly neglected, but should be taken into account for a meaningful analysis. In this study, the importance of the choice of protein source used for in vitro protein corona analysis is concisely investigated. Major and decisive differences in cellular uptake of a polystyrene nanoparticle incubated in fetal bovine serum, human serum, human citrate and heparin plasma are reported. Furthermore, the protein compositions are determined for coronas formed in the respective incubation media. A strong influence of heparin, which is used as an anticoagulant for plasma generation, on cell interaction is demonstrated. While heparin enhances the uptake into macrophages, it prevents internalization into HeLa cells. Taken together we can give the recommendation that human plasma anticoagulated with citrate seems to give the most relevant results for in vitro studies of nanoparticle uptake.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26804616     DOI: 10.1039/c5nr08196c

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  24 in total

Review 1.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

Review 2.  Personalized protein corona on nanoparticles and its clinical implications.

Authors:  Claudia Corbo; Roberto Molinaro; Mateen Tabatabaei; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

3.  SWATH-MS Protocols in Human Diseases.

Authors:  Maria Del Pilar Chantada-Vázquez; María García Vence; Antonio Serna; Cristina Núñez; Susana B Bravo
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Cellular uptake of nanoparticles: journey inside the cell.

Authors:  Shahed Behzadi; Vahid Serpooshan; Wei Tao; Majd A Hamaly; Mahmoud Y Alkawareek; Erik C Dreaden; Dennis Brown; Alaaldin M Alkilany; Omid C Farokhzad; Morteza Mahmoudi
Journal:  Chem Soc Rev       Date:  2017-07-17       Impact factor: 54.564

5.  Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.

Authors:  Daniel J Sobczynski; Omolola Eniola-Adefeso
Journal:  Acta Biomater       Date:  2016-10-17       Impact factor: 8.947

6.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-30

Review 7.  Sex as an important factor in nanomedicine.

Authors:  Mohammah Javad Hajipour; Haniyeh Aghaverdi; Vahid Serpooshan; Hojatollah Vali; Sara Sheibani; Morteza Mahmoudi
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

8.  Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona.

Authors:  Klemen Strojan; Adrijana Leonardi; Vladimir B Bregar; Igor Križaj; Jurij Svete; Mojca Pavlin
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

9.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part I: In vitro Release and Intracellular Uptake Perspective.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-10

10.  Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.

Authors:  Min Wu; Dajun Sun; Katherine Tyner; Wenlei Jiang; Rodney Rouse
Journal:  Nanomaterials (Basel)       Date:  2017-12-15       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.